Attention deficit disorders

FDA approves marketing of first device to treat ADHD

(HealthDay)—Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder (ADHD), the U.S. Food and Drug Administration announced Friday.

Attention deficit disorders

Trigeminal nerve stimulation beats sham tx for peds ADHD

(HealthDay)—Trigeminal nerve stimulation (TNS) showed efficacy when compared with a similar sham procedure for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, according to a double-blind, controlled ...

Attention deficit disorders

More sleep may help teens with ADHD focus and organize

Teenagers with attention deficit hyperactivity disorder (ADHD) may benefit from more sleep to help them focus, plan and control their emotions. The findings—the first of their kind in young people with ADHD—will be presented ...

Attention deficit disorders

Dasotraline promising for the treatment of ADHD in children

(HealthDay)—Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder (ADHD) symptoms in children aged 6 to 12 years, according to a study published online March 7 in the Journal ...

page 28 from 40